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Objective: To present a rare case of recurrent ovarian clear cell carcinoma (OCCC) with systemic embolic
events.
Case report: A 60-year-old woman with a history of OCCC presented with an acute ischemic stroke.
Magnetic resonance imaging showed multifocal, bilateral infarctions over the cerebrum and cerebellum.
An echocardiogram revealed vegetation growth in the mitral and tricuspid valves and showed no evi-
dence of atrial ﬁbrillation. The serological studies for stroke were negative for all assessed parameters
(normal values of protein C, protein S, antithrombin III, and lupus anticoagulant antibodies). Computed
tomography of the abdomen and pelvis revealed bilateral renal and splenic infarctions, as well as
enlarged pelvic lymph nodes due to a recurrent ovarian neoplasm. We diagnosed the patient with
nonbacterial thrombotic endocarditis (NBTE) based on serial negative blood cultures and sterile vege-
tation of the surgical specimen.
Conclusion: NBTE should be considered among the possible causes of multifocal embolic infarctions and
as an early manifestation of recurrent OCCC. Anticoagulant therapy is the mainstay of treatment, and
dual anticoagulation therapies are necessary to reduce the risk of recurrent thromboembolism.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Women with ovarian cancer may present with a range of
symptoms, including bloating, pelvic or abdominal pain, difﬁculty
eating, early satiety, urinary urgency, or increased frequency of
urination [1]. Nonbacterial thrombotic endocarditis (NBTE), also
known as marantic endocarditis, is a rare manifestation in ovarian
cancer and usually precedes the diagnosis of malignancy [2]. NBTE
is characterized by deposition of ﬁbrin and platelets on the heart
valves in the absence of a bloodstream bacterial infection and acute
inﬂammatory reaction, which predominantly occurs in mucin-Tri-Service General Hospital,
n 2, Cheng-gong Road, Neihu
u.tw, drshyu@seed.net.tw
bstetrics & Gynecology. Publishedproducing adenocarcinomas, such as acute leukemia or pancre-
atic, lung, and gastric cancers [3,4].
In this paper, we describe a rare case of recurrent ovarian clear
cell carcinoma (OCCC) in a 60-year-old woman who developed
aseptic vegetation on the mitral and tricuspid valves and experi-
enced systemic embolisms.Case Report
A 60-year-old woman presented with acute onset of an unstable
gait, urinary incontinence, apathy, and mutism for 3 days. The pa-
tient's medical history included Type 2 diabetes mellitus, hyper-
tension, and Stage IIIC OCCC, which was treated with debulking
surgery followed by ﬁve cycles of adjuvant chemotherapy 10 years
previously. Postoperatively, the patient had regular follow-up visits
for 5 years at the Gynecological Outpatient Department (Tri-Service
General Hospital, Taipei City). The patient denied any symptoms of
bloating, abdominal pain, or early satiety. Regular computedby Elsevier Taiwan LLC. All rights reserved.
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enlargement or ascites (Figure 1A), and her cancer antigen-125 (CA-
125) level was 14.29 U/mL (normal range 0e35 U/mL). Her family
history indicated that one brother developed lymphoma, and
another was diagnosed with hepatocellular carcinoma. On initial
physical examination, she was in no acute distress, was afebrile,
and had a heart rate of 80 beats/min with normal blood pressure.
Cardiac examination revealed a normal rhythm with no
detectable murmurs or irregular sounds, and her lungs were clear
on auscultation. An abdominal examination by palpation demon-
strated no tenderness or a palpable mass. A neurological exami-
nation revealed acalculia, mutism, and recentmemory impairment.
Initial laboratory study results were as follows: white blood cell
count of 6.66  103/mL with a neutrophil count of 4.51  103/mL;
hemoglobin level of 10.1 g/dL; platelet count of 124  103/mL;
troponin level of 0.45 ng/mL; total creatine kinase level of 154 U/L;
creatinine level of 0.9 mg/dL; international normalized ratio of 1.1;
prothrombin time of 11.9 seconds; partial thromboplastin time of
24.9 seconds; ﬁbrinogen level of 627.9 mg/dL; ﬁbrin degradation
products of 8301 ng/mL; and D-dimer level of 11.94 mg/L. Her
electrocardiogram monitoring showed ﬁndings consistent with a
normal sinus rhythm.
A stroke protocol was initiated, and magnetic resonance im-
aging of the brain showed diffuse acute lacunar infarcts in the
bilateral cerebra and cerebella without occlusion or stenosis of the
intracranial arteries (Figure 2), suggestive of an embolic stroke. An
echocardiogram showed severe mitral regurgitation and oscilla-
tion, with moderate-sized vegetation on the mitral valve leaﬂet
(0.7  0.6 cm2; Figure 3A) and tricuspid valve leaﬂet
(0.6  0.5 cm2; Figure 3B). Other confounding factors for stroke,
including levels of protein C, protein S, immunoglobulin, anti-
thrombin III, anticardiolipin immunoglobulin G, lupus anticoag-
ulant, antistreptolysin O titer, rheumatoid factor, rapid plasma
reagin, and antihuman immunodeﬁciency virus antibodies, were
within normal limits. Tumor markers were assessed, and the level
of CA-125 was 133.9 U/mL (normal range 0e35 U/mL). The patient
was lost to follow up at the Gynecological Outpatient Department
for approximately 5 years. Based on the neuroimaging results,
cancer-related hypercoagulation resulting in acute ischemic
stroke was still strongly considered at the time of the stroke
attack. Therefore, tumor markers were evaluated accordingly, and
the level of CA-125 was found to be 133.9 U/mL (normal range
0e35 U/mL). The gynecology specialist was consulted regarding
the elevated CA-125 level. Pelvic examination and transvaginal
ultrasound showed absence of the uterus and ovaries, however,
mild ascites was observed over the pelvis. Recurrent OCCC was
suspected.Figure 1. Contrast-enhanced computed tomography revealed (A) no evidence of para-aorti
the spleen and kidneys and (C) enlarged nodes (size < 2.7 cm) in the right pelvic cavity, ﬁnd
removed.A CT examination was performed for recurrent malignancy
work-up and showed numerous large, edge-shaped hypodensities
in the spleen and bilateral kidneys (Figure 1B), consistent with
infarcts. Enlarged nodes (size < 2.7 cm) were noted in the para-
aortic space, and in the right common and internal iliac chains
(Figure 1C), indicating recurrent OCCC. The patient did not undergo
tissue biopsy due to coagulopathy and the deep location of the
tumor and nodes.
The patient was suspected of having infective endocarditis, and
empiric therapy was initiated with ceftriaxone plus vancomycin.
Despite persistent low-grade fevers, serial blood cultures remained
sterile. The patient received an antiplatelet agent (ticlopidine
250mg/d) and anticoagulation therapy with a vitamin K antagonist
(warfarin 2 mg/d) for secondary stroke prevention. However, a
stroke-in-evolution was noted, with new onset of motor aphasia
and right-sided hemiparesis during hospitalization. Heparin infu-
sion was initiated immediately, and the patient's neurological
deﬁcits improved partially. On Day 14 of hospitalization, the patient
underwent surgery for removal of the vegetations and valve
replacement to prevent recurrent embolic events. The sterile na-
ture of the vegetations was conﬁrmed by pathological examination
and negative cultures of the surgical samples. A diagnosis of
infective endocarditis was therefore excluded. The patient was
successfully extubated on postoperative Day 4 and transferred to a
standard hospital room. A gynecology specialist was consulted, and
chemotherapy was suggested for control of the underlying malig-
nancy. Dual anticoagulation therapies of oral warfarin and intra-
venous heparin were initially administered after the surgery.
Unfortunately, the patient died of pneumonia with sepsis on hos-
pital Day 29.
Discussion
Patients with cancer are in a hypercoagulable state. Thrombotic
events may precede the diagnosis of malignancy in migratory su-
perﬁcial thrombophlebitis (Trousseau's syndrome), chronic
disseminated intravascular coagulation, or NBTE [2]. Adenocarci-
noma of the ovary has been previously described as a cause of
NBTE, however, only three cases of OCCC have been reported in the
literature [5e7].
Our case presentation is the ﬁrst to describe the relationship
between tumor recurrence and NBTE. Our patient initially pre-
sented with recurrent OCCC along with acute multifocal cerebral
and cerebellar infarctions. A transthoracic echocardiogram identi-
ﬁed severe mitral regurgitation and oscillating, moderate-sized
vegetation on the mitral valve leaﬂet and tricuspid valve leaﬂet. A
contrast-enhanced CT scan of the abdomen showed numerousc lymph node enlargement or ascites, but did show (B) multiple low-density lesions in
ings consistent with recurrent tumor with embolic infarcts. The ovary and uterus were
Figure 2. Diffusion-weighted images showed multiple areas of restricted water diffusion in (A, B) the bilateral cerebra and (C, D) the cerebella, ﬁndings consistent with embolic
infarcts.
Figure 3. Transthoracic echocardiogram illustrating (A) mitral valve and (B) tricuspid valve vegetations. (C) The small pink vegetation represents a typical ﬁnding with nonbacterial
thrombotic endocarditis without valve destruction.
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serology study was negative for all parameters assessed (normal
values of protein C, protein S, antithrombin III, and lupus antico-
agulant antibodies).
The deﬁnitive diagnosis of NBTE can be made by demonstrating
the presence of platelet thrombi on autopsy or surgical specimens.
In clinical practice, a diagnosis of NBTE depends on a constellation
of clinical and echocardiographic ﬁndings, as well as an absence of
microbiologic ﬁndings. Typically, the demonstration of valvular
vegetations on echocardiography in the absence of systemic
infection in patients who are at high risk of NBTE provides strong
evidence to support the diagnosis [8]. In our case, cancer-related
NBTE was proven based on a high level of CA-125, CT ﬁndings
consistent with recurrent tumor (Figure 1C) with embolic infarcts
(Figure 1B), serial negative blood cultures, negative cultures of the
surgical samples, typical transthoracic echocardiogram (Figure 3A),
and surgical specimens (Figure 3C).Unlike infective endocarditis, NBTE has a higher potential for
embolization due to limited cellular organization and mobile
properties [7]. Systemic embolism occurs in 14e91% of NBTE cases
and usually affects cerebral, coronary, renal, and mesenteric cir-
culation [3,9]. In our case, the patient was diagnosed with stroke-
in-evolution, bilateral renal infarction, and splenic infarctions by
imaging modalities.
It is critically important to distinguish between NBTE and
infective endocarditis, because these conditions have different
therapeutic plans. The diagnosis of infective endocarditis is based
on clinical, microbiologic, and echocardiographic ﬁndings together
with Duke's criteria [10]. The treatment approach for patients with
infective endocarditis includes appropriate antibiotic treatment
with consideration of valve replacement if heart failure or uncon-
trolled infection occurs, as well as treatment for the prevention of
embolic events [11]. The application of cardiac surgery in NBTE is
controversial; however, in our case, valve replacement was strongly
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regurgitation and tricuspid valve regurgitation), stroke prophylaxis,
and possible infective endocarditis [12].
Treatment of patients with NBTE is challenging, and therapeutic
goals are typically directed at curing the underlying malignancy
and systemic anticoagulation. Monotherapy with vitamin K an-
tagonists in patients with malignancy-associated NBTE is not rec-
ommended because recurrent thromboembolic events have been
commonly observed in patients receiving warfarin alone [13]. In
our case, we initially administered an antiplatelet drug and vitamin
K antagonist (warfarin) for stroke prevention. Stroke-in-evolution
was noted on neurological examination, with symptoms of acal-
culia, mutism, and recent memory impairment, followed by the
onset of motor aphasia and decline in muscle power in the right
limbs. The patient immediately received a heparin infusion, and the
symptoms quickly improved. Dual anticoagulation therapies were
necessary due to the hypercoagulable state of OCCC-related NBTE.
Therefore, chemotherapy should be initiated immediately if the
patient has a good performance status.
In conclusion, our case report underscores that NBTE should be
considered among the possible causes of multifocal embolic in-
farctions and as an early manifestation of OCCC recurrence. Dual
anticoagulation therapy with heparin and warfarin is necessary to
reduce the risk of recurrent thromboembolism. Recurrent OCCC
with NBTE and systemic embolisms can cause morbidity and
mortality if diagnosis is delayed. Early recognition, together with
appropriate clinical management, can improve the patient's quality
of life and prognosis.
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